Jupiter Topco LLC bought a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 59,714 shares of the company's stock, valued at approximately $3,821,000.
Several other institutional investors also recently bought and sold shares of GEHC. Hsbc Holdings PLC lifted its stake in shares of GE HealthCare Technologies by 22.8% during the 2nd quarter. Hsbc Holdings PLC now owns 1,004,490 shares of the company's stock worth $64,217,000 after purchasing an additional 186,800 shares during the period. Aberdeen Wealth Management LLC purchased a new stake in shares of GE HealthCare Technologies in the second quarter valued at $44,000. Arete Wealth Advisors LLC purchased a new stake in shares of GE HealthCare Technologies in the second quarter valued at $942,000. Barrow Hanley Mewhinney & Strauss LLC increased its stake in GE HealthCare Technologies by 13.2% in the second quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 13,455,814 shares of the company's stock valued at $861,307,000 after purchasing an additional 1,571,226 shares during the last quarter. Finally, Nixon Capital LLC purchased a new position in GE HealthCare Technologies during the second quarter worth about $13,671,000. 82.06% of the stock is currently owned by institutional investors and hedge funds.
GE HealthCare Technologies Trading Down 1.1%
Shares of GEHC stock opened at $70.42 on Wednesday. The stock has a market cap of $31.81 billion, a price-to-earnings ratio of 16.15, a price-to-earnings-growth ratio of 1.88 and a beta of 0.70. The company has a quick ratio of 0.97, a current ratio of 1.26 and a debt-to-equity ratio of 0.92. GE HealthCare Technologies Inc. has a fifty-two week low of $58.75 and a fifty-two week high of $89.77. The firm's 50 day moving average price is $68.02 and its two-hundred day moving average price is $69.14.
GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings data on Wednesday, July 29th. The company reported $1.13 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.04 by $0.09. GE HealthCare Technologies had a net margin of 9.33% and a return on equity of 20.12%. The company had revenue of $5.29 billion during the quarter, compared to analyst estimates of $5.26 billion. During the same quarter in the prior year, the business earned $1.06 earnings per share. The business's quarterly revenue was up 5.8% compared to the same quarter last year. On average, analysts anticipate that GE HealthCare Technologies Inc. will post 4.93 EPS for the current year.
GE HealthCare Technologies Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Friday, August 14th. Investors of record on Friday, July 24th were given a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend was Friday, July 24th. GE HealthCare Technologies's dividend payout ratio is 3.21%.
Analyst Ratings Changes
A number of brokerages have issued reports on GEHC. BTIG Research reissued a "buy" rating and issued a $79.00 price target on shares of GE HealthCare Technologies in a research note on Wednesday, August 19th. Weiss Ratings reiterated a "hold (c-)" rating on shares of GE HealthCare Technologies in a report on Wednesday, August 12th. Oppenheimer reissued an "outperform" rating on shares of GE HealthCare Technologies in a research report on Thursday, July 30th. Wells Fargo & Company boosted their target price on shares of GE HealthCare Technologies from $75.00 to $85.00 and gave the company an "overweight" rating in a report on Thursday, July 30th. Finally, Argus dropped their price target on shares of GE HealthCare Technologies from $95.00 to $80.00 and set a "buy" rating for the company in a research report on Tuesday, May 19th. Ten research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $77.73.
Get Our Latest Research Report on GE HealthCare Technologies
GE HealthCare Technologies Profile
(
Free Report)
GE HealthCare Technologies NASDAQ: GEHC is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.
In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.
Further Reading
Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider GE HealthCare Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.
While GE HealthCare Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
